FDA approves new nasal spray for migraines

And tonight's health watch important news for nearly 40 million Americans who suffer from migraine headaches. The FDA has approved a new nasal spray to treat migraines called Zavspret. Drugmaker Pfizer says the new medication can begin treating symptoms in as little as 15 minutes. It's expected to be available in pharmacies in July.

FDA, food and drug administration, nasal spray, migraines, headaches, healthcare